Department of Medical Neurobiology, Institute of Medical Research Israel - Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, 9112102, Jerusalem, Israel.
Eur J Neurosci. 2019 Mar;49(6):824-833. doi: 10.1111/ejn.13715. Epub 2017 Oct 6.
The widely held view that the pathophysiology of Parkinson's disease arises from an under-activation of the direct pathway striatal spiny neurons (dSPNs) has gained support from a recently described weakening of the glutamatergic projection from the parafascicular nucleus (PfN) to dSPNs in experimental parkinsonism. However, the impact of the remodeling of the thalamostriatal projection cannot be fully appreciated without considering its impact on cholinergic interneurons (ChIs) that themselves preferentially activate indirect pathway spiny neurons (iSPNs). To study this thalamostriatal projection, we virally transfected with Cre-dependent channelrhodopsin-2 (ChR2) the PfN of Vglut2-Cre mice that were dopamine-depleted with 6-hydroxydopamine (6-OHDA). In parallel, we studied the corticostriatal projection to ChIs in 6-OHDA-treated transgenic mice expressing ChR2 under the Thy1 promoter. We found the 6-OHDA lesions failed to affect short-term synaptic plasticity or the size of unitary responses evoked optogenetically in either of these projections. However, we found that NMDA-to-AMPA ratios at PfN synapses-that were significantly larger than NMDA-to-AMPA ratios at cortical synapses-were reduced by 6-OHDA treatment, thereby impairing synaptic integration at PfN synapses onto ChIs. Finally, we found that application of an agonist of the D dopamine receptors on ChIs potentiated NMDA currents without affecting AMPA currents or short-term plasticity selectively at PfN synapses. We propose that dopamine depletion leads to an effective de-potentiation of NMDA currents at PfN synapses onto ChIs which degrades synaptic integration. This selective remodeling of NMDA currents at PfN synapses may counter the selective weakening of PfN synapses onto dSPNs in parkinsonism.
帕金森病的病理生理学源自直接通路纹状体棘神经元(dSPNs)活性不足的普遍观点得到了最近描述的实验性帕金森病中旁束核(PfN)到 dSPNs 的谷氨酸能投射减弱的支持。然而,如果不考虑其对选择性激活间接通路棘神经元(iSPNs)的胆碱能中间神经元(ChIs)的影响,就无法充分了解丘脑纹状体投射的重塑。为了研究这条丘脑纹状体投射,我们在 Vglut2-Cre 小鼠的 PfN 中转染了 Cre 依赖性通道视紫红质-2(ChR2),这些小鼠因 6-羟多巴胺(6-OHDA)而多巴胺耗竭。平行地,我们在表达 ChR2 的 Thy1 启动子下的 6-OHDA 处理的转基因小鼠中研究了皮质纹状体投射到 ChIs。我们发现,6-OHDA 损伤未能影响这两种投射中的短期突触可塑性或光遗传学诱发的单位反应的大小。然而,我们发现 PfN 突触的 NMDA 到 AMPA 比值显著大于皮质突触的 NMDA 到 AMPA 比值,而 6-OHDA 处理降低了 NMDA 到 AMPA 的比值,从而损害了 PfN 突触对 ChIs 的突触整合。最后,我们发现,在 ChIs 上应用 D 多巴胺受体激动剂增强了 NMDA 电流,而不影响 AMPA 电流或短期可塑性,选择性地作用于 PfN 突触。我们提出,多巴胺耗竭导致 PfN 突触上 NMDA 电流的有效去极化,从而降低了突触整合。这种 PfN 突触上 NMDA 电流的选择性重塑可能会抵消帕金森病中 PfN 突触对 dSPNs 的选择性减弱。